Breaking News, Promotions & Moves

Ubiquigent Names Rishi Shah Head of Chemistry

Shah brings extensive heterobifunctional and chemical biology expertise to drive internal DUBTAC drug discovery and DUB-focused partnerships.

Ubiquigent Ltd., a drug discovery and development company, appointed Rishi Shah head of chemistry. With extensive expertise in heterobifunctional molecules, Shah will support Ubiquigent’s internal drug discovery and strategic partnerships in the design, discovery, and development of DUB inhibitors, DUB-targeting Proteolysis Targeting Chimeras (PROTACs) and DUB-targeting Chimeras (DUBTACs). Shah joins Ubiquigent from GlaxoSmithKline where he led the development of multiple targeted protein deg...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters